The main reasons for this phenomenon may be due to the different positions of CDKN1A and CDKN2A in the melanoma pathway and cell cycle pathway, as well as differences in upstream regulatory networks (eg. TP53 and GADD45B). The gene discussed is CDKN2A; the disease is melanoma.